<DOC>
	<DOC>NCT00273507</DOC>
	<brief_summary>Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3</brief_title>
	<detailed_description>Randomisation between 3 courses of neoadjuvant Carboplatin plus Paclitaxel or no chemotherapy before surgery.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>NSCLC Stages IB, IIA, IIB, IIIA/T3 Lung function test allowing surgery Age 1875 years Poor lung function Performance status 34 Mediastinal lymph node involvement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>neoadjuvant</keyword>
	<keyword>resection</keyword>
</DOC>